Physician profile
Chad Derosa
NPI 1740471275
$7,580.69
in general payments reported to CMS, 2019-2025
13 companies · $1,667 in 2025
The $1,667 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,180 · 2024: $4,734 · 2025: $1,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,208 · Food and Beverage: $2,319 · Education: $53.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,207.87 |
| Food and Beverage | $2,318.92 |
| Education | $53.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $6,059.91 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Teleflex LLC | $865.81 | 2024-2025 | Urolift, Barrigel |
| Urogen Pharma, INC. | $138.70 | 2025 | |
| Boston Scientific Corporation | $103.70 | 2023-2025 | Ams 700, Spaceoar Vue System - 10ml, Rezum Generator |
| Sumitomo Pharma America, INC. | $95.78 | 2025 | Orgovyx |
| Convatec INC. | $84.61 | 2024-2025 | |
| Axonics, INC. | $54.51 | 2023-2024 | Axonics, Bulkamid |
| Calyxo, INC. | $51.28 | 2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $43.55 | 2024-2025 | Prolaris |
| Merck Sharp & Dohme LLC | $27.48 | 2025 | Keytruda, Welireg |
| Astellas Pharma US INC | $24.96 | 2025 | Xtandi |
| Dentsply Ih Ab | $16.08 | 2025 | Lofric |
| C. R. Bard, INC. & Subsidiaries | $14.32 | 2025 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Derosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.